Keyphrases
Bacillus Isolates
25%
Carbapenem Resistance
25%
Carbapenem-resistant Acinetobacter Baumannii
25%
Clinical Infectious Diseases
25%
Clinical Issues
25%
Clinical Microbiology
25%
Clinical Pharmacology
25%
Enterobacteria
25%
Evidence Profile
25%
Extensively Drug-resistant
25%
Gram-negative Bacilli
100%
Group Covering
25%
Guideline Development Group
25%
Guideline Methodology
25%
Guideline-based
25%
Infection Control
100%
Infection Prevention
100%
Multidisciplinary Guideline
25%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
25%
Pandrug-resistant
25%
Population Interventions
25%
Strength of Recommendations
25%
Medicine and Dentistry
Acinetobacter Baumannii
14%
Carbapenem
100%
Infection Control
14%